Ebola Rapid Diagnostic Tests: What Lies Ahead?
As the Ebola epidemic continues in West Africa, a major challenge impeding international efforts to “get to zero” Ebola cases and deaths is the absence of effective, portable, and affordable Ebola diagnostic tools. There has been a considerable push by industry, governments, NGOs, international organizations, and foundations to develop these new tests. While there are many promising tools on the horizon, there are still a number of challenges and unknowns that need to be considered in terms of research and development, and implementation.
Our panel will include:
Dr. Michael Kurilla
Director of the National Institute of Allergies and Infectious Diseases (NIAID) Office of BioDefense, Research Resources, and Translational Research
Diagnostic Science Advisor at the Biomedical Advanced Research and Development Authority (BARDA)
Independent Consultant to the Paul G. Allen Family Foundation on Ebola Diagnostics
J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center